{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:25:59Z","timestamp":1791930359977,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mehy.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T04:23:49Z","timestamp":1445401429000},"page":"835-841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A biopsychosocial model of fatigue and depression following stroke"],"prefix":"10.1016","volume":"85","author":[{"given":"Heidi","family":"Ormstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe","family":"Eilertsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1176\/ajp.137.5.535","article-title":"The clinical application of the biopsychosocial model","volume":"137","author":"Engel","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0010","first-page":"362","article-title":"Development of the biopsychosocial model of medicine","volume":"15","author":"Sadigh","year":"2013","journal-title":"Virtual Mentor"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychores.2012.04.001","article-title":"Frequency and natural history of fatigue after stroke: a systematic review of longitudinal studies","volume":"73","author":"Duncan","year":"2012","journal-title":"J Psychosom Res"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000139660","article-title":"Dimensions of post-stroke fatigue: a two-year follow-up study","volume":"26","author":"Christensen","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1468-1331.2010.03217.x","article-title":"Time course and risk factors of post-stroke fatigue: a prospective cohort study","volume":"18","author":"Snaphaan","year":"2011","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MRR.0b013e328010c7b8","article-title":"Prevalence and predictors of pain and fatigue after stroke: a population-based study","volume":"29","author":"Appelros","year":"2006","journal-title":"Int J Rehabil Res"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000087706","article-title":"Fatigue at long-term follow-up in young adults with cerebral infarction","volume":"20","author":"Naess","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000082784","article-title":"Poststroke fatigue: characteristics and related factors","volume":"19","author":"Choi-Kwon","year":"2005","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000347113","article-title":"CT and clinical predictors of fatigue at one month after stroke","volume":"3","author":"Kutlubaev","year":"2013","journal-title":"Cerebrovasc Dis Extra"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0050","doi-asserted-by":"crossref","first-page":"e16988","DOI":"10.1371\/journal.pone.0016988","article-title":"Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial","volume":"6","author":"Mead","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1176\/appi.neuropsych.11110325","article-title":"Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue","volume":"24","author":"Karaiskos","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2015.10.001_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000097045","article-title":"Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study","volume":"23","author":"Choi-Kwon","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.mehy.2015.10.001_b0065","first-page":"CD007030","article-title":"Interventions for post-stroke fatigue","volume":"3","author":"McGeough","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0070","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/STROKEAHA.111.632117","article-title":"Cognitive and graded activity training can alleviate persistent fatigue after stroke: a randomized, controlled trial","volume":"43","author":"Zedlitz","year":"2012","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0075","first-page":"240","article-title":"Biological correlates of post-stroke fatigue: a systematic review","volume":"22","author":"Kutlubaev","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2008.08.019","article-title":"Systemic infection, inflammation and acute ischemic stroke","volume":"158","author":"McColl","year":"2009","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s11481-013-9469-1","article-title":"The immune system in stroke: clinical challenges and their translation to experimental research","volume":"8","author":"Smith","year":"2013","journal-title":"J Neuroimmune Pharmacol"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.001_b0090","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","article-title":"Inflammatory cytokines in experimental and human stroke","volume":"32","author":"Lambertsen","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2015.10.001_b0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2006.11.014","article-title":"The inflammatory response in stroke","volume":"184","author":"Wang","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2015.10.001_b0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mcn.2012.08.011","article-title":"The effect of stroke on immune function","volume":"53","author":"Brambilla","year":"2013","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00401-009-0496-1","article-title":"Inflammation, plasticity and real-time imaging after cerebral ischemia","volume":"117","author":"Kriz","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0022-510X(94)90289-5","article-title":"Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease","volume":"122","author":"Fassbender","year":"1994","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.001_b0115","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/01.STR.26.8.1393","article-title":"Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke","volume":"26","author":"Tarkowski","year":"1995","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.001_b0120","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.STR.31.10.2325","article-title":"Proinflammatory cytokines and early neurological worsening in ischemic stroke","volume":"31","author":"Vila","year":"2000","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.001_b0125","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1161\/01.STR.0000079815.38626.44","article-title":"Multiple levels of regulation of the interleukin-6 system in stroke","volume":"34","author":"Acalovschi","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.mehy.2015.10.001_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-4-2","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"4","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.001_b0135","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.STR.0000165929.78756.ed","article-title":"Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members","volume":"36","author":"Di Napoli","year":"2005","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2015.10.001_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2006.09.011","article-title":"Variability of the systemic acute phase response after ischemic stroke","volume":"251","author":"Smith","year":"2006","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0145","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1468-1331.2006.01280.x","article-title":"Inflammatory biomarkers in blood of patients with acute brain ischemia","volume":"13","author":"Sotgiu","year":"2006","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1160\/TH08-06-0375","article-title":"Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke","volume":"101","author":"Licata","year":"2009","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0155","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00415-011-6006-0","article-title":"Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume","volume":"258","author":"Ormstad","year":"2011","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s00415-011-5962-8","article-title":"Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients","volume":"258","author":"Ormstad","year":"2011","journal-title":"J Neurol"},{"key":"10.1016\/j.mehy.2015.10.001_b0165","first-page":"1827","article-title":"Kynurenine and depressive symptoms in a poststroke population","volume":"10","author":"Bensimon","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-1-22","article-title":"On the potential role of glutamate transport in mental fatigue","volume":"1","author":"Ronnback","year":"2004","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.001_b0180","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1521-4141(200108)31:8<2313::AID-IMMU2313>3.0.CO;2-S","article-title":"Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism","volume":"31","author":"Fujigaki","year":"2001","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.mehy.2015.10.001_b0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/jir.1997.17.589","article-title":"Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha","volume":"17","author":"Pemberton","year":"1997","journal-title":"J Interferon Cytokine Res"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.001_b0190","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00109-007-0229-7","article-title":"IDO expression in the brain: a double-edged sword","volume":"85","author":"Kwidzinski","year":"2007","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.mehy.2015.10.001_b0195","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-013-0097-2","article-title":"Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke","author":"Ormstad","year":"2013","journal-title":"J Mol Neurosci"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.001_b0200","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","article-title":"Altered kynurenine metabolism correlates with infarct volume in stroke","volume":"26","author":"Darlington","year":"2007","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jocn.2013.08.020","article-title":"Serum indoleamine 2,3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke","volume":"21","author":"Mo","year":"2014","journal-title":"J Clin Neurosci"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.001_b0210","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","article-title":"The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke","volume":"35","author":"Brouns","year":"2010","journal-title":"Neurochem Res"},{"issue":"3\u20134","key":"10.1016\/j.mehy.2015.10.001_b0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0028-3908(94)90089-2","article-title":"Tryptophan depletion in normal volunteers produces selective impairments in learning and memory","volume":"33","author":"Park","year":"1994","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0220","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130050845","article-title":"Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation","volume":"141","author":"Riedel","year":"1999","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s007020050029","article-title":"Tryptophan degradation and immune activation in Alzheimer\u2019s disease","volume":"107","author":"Widner","year":"2000","journal-title":"J Neural Transm"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer\u2019s disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.mehy.2015.10.001_b0235","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-8-17","article-title":"The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment","volume":"8","author":"Gold","year":"2011","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.mehy.2015.10.001_b0240","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-014-0272-0","article-title":"Activation of the kynurenine pathway in the acute phase of stroke and its role in fatigue and depression following stroke","author":"Ormstad","year":"2014","journal-title":"J Mol Neurosci"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0245","doi-asserted-by":"crossref","first-page":"e36956","DOI":"10.1371\/journal.pone.0036956","article-title":"Fatigue in patients with lung cancer is related with accelerated tryptophan breakdown","volume":"7","author":"Kurz","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.mehy.2015.10.001_b0250","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","article-title":"Diminished quality of life in patients with cancer correlates with tryptophan degradation","volume":"133","author":"Schroecksnadel","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0255","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1017\/S031716710001266X","article-title":"Essential role of excessive tryptophan and its neurometabolites in fatigue","volume":"39","author":"Yamamoto","year":"2012","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0260","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/jan.12002","article-title":"Experiences of poststroke fatigue: qualitative meta-synthesis","volume":"69","author":"Eilertsen","year":"2013","journal-title":"J Adv Nurs"},{"issue":"6","key":"10.1016\/j.mehy.2015.10.001_b0265","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1310\/tsr2006-478","article-title":"Poststroke fatigue: the patient perspective","volume":"20","author":"Young","year":"2013","journal-title":"Top Stroke Rehabil"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1471-6712.2003.00217.x","article-title":"The first year of rehabilitation after a stroke \u2013 from two perspectives","volume":"17","author":"Bendz","year":"2003","journal-title":"Scand J Caring Sci"},{"issue":"23","key":"10.1016\/j.mehy.2015.10.001_b0275","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/09638280400000211","article-title":"A qualitative study of the consequences of \u2018hidden dysfunctions\u2019 one year after a mild stroke in persons <75years","volume":"26","author":"Carlsson","year":"2004","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.mehy.2015.10.001_b0280","first-page":"863031","article-title":"Fatigue after stroke: the patient\u2019s perspective","volume":"2012","author":"Barbour","year":"2012","journal-title":"Stroke Res Treat"},{"issue":"8","key":"10.1016\/j.mehy.2015.10.001_b0285","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3109\/09638288.2011.615373","article-title":"Fatigue after stroke: manifestations and strategies","volume":"34","author":"Kirkevold","year":"2012","journal-title":"Disabil Rehabil"},{"issue":"16","key":"10.1016\/j.mehy.2015.10.001_b0290","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3109\/09638288.2011.645111","article-title":"Exploring the experience of post-stroke fatigue in community dwelling stroke survivors: a prospective qualitative study","volume":"34","author":"White","year":"2012","journal-title":"Disabil Rehabil"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0295","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/j.2048-7940.1998.tb01782.x","article-title":"Life after a stroke: coping with change","volume":"23","author":"Sisson","year":"1998","journal-title":"Rehabil Nurs"},{"issue":"19","key":"10.1016\/j.mehy.2015.10.001_b0300","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/09638280802639327","article-title":"Resuming previously valued activities post-stroke: who or what helps?","volume":"31","author":"Robison","year":"2009","journal-title":"Disabil Rehabil"},{"issue":"15","key":"10.1016\/j.mehy.2015.10.001_b0305","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/0963828031000122276","article-title":"Frustrated and invisible \u2013 younger stroke patients\u2019 experiences of the rehabilitation process","volume":"25","author":"Roding","year":"2003","journal-title":"Disabil Rehabil"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpainsymman.2003.07.006","article-title":"Coping with long-term pain after a stroke","volume":"27","author":"Widar","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/oti.286","article-title":"Post-stroke fatigue: qualitative study of three focus groups","volume":"17","author":"Flinn","year":"2010","journal-title":"Occup Ther Int"},{"issue":"22","key":"10.1016\/j.mehy.2015.10.001_b0320","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.12968\/bjon.2002.11.22.10953","article-title":"Recovering from subarachnoid haemorrhage: patients\u2019 perspective","volume":"11","author":"Jarvis","year":"2002","journal-title":"Br J Nurs"},{"issue":"12","key":"10.1016\/j.mehy.2015.10.001_b0325","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/j.1365-2702.2008.02694.x","article-title":"The impact of stroke consequences on spousal relationships from the perspective of the person with stroke","volume":"18","author":"Thompson","year":"2009","journal-title":"J Clin Nurs"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0330","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1192\/bjp.bp.111.107664","article-title":"Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis","volume":"202","author":"Ayerbe","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.mehy.2015.10.001_b0335","first-page":"Cd009286","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery","volume":"11","author":"Mead","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.mehy.2015.10.001_b0340","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1179\/174313209X385752","article-title":"Etiological mechanisms of post-stroke depression: a review","volume":"31","author":"Fang","year":"2009","journal-title":"Neurol Res"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.001_b0345","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.mp.4001879","article-title":"The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines","volume":"11","author":"Spalletta","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0350","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","article-title":"The macrophage theory of depression","volume":"35","author":"Smith","year":"1991","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","article-title":"Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness","volume":"17","author":"Maes","year":"1993","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","article-title":"Indicators of immune activation in major depression","volume":"64","author":"Sluzewska","year":"1996","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0365","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","article-title":"Cytokine imbalance in the pathophysiology of major depressive disorder","volume":"31","author":"Kim","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0370","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0375","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0380","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2015.10.001_b0385","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.mehy.2015.10.001_b0390","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3109\/00207454.2012.709892","article-title":"Serum levels of cytokines, glucose, and hemoglobin as possible predictors of poststroke depression, and association with poststroke fatigue","volume":"122","author":"Ormstad","year":"2012","journal-title":"Int J Neurosci"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0395","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0400","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0405","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0327(89)90051-7","article-title":"Decreased plasma tryptophan levels in major depression","volume":"16","author":"Cowen","year":"1989","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0410","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000119071","article-title":"Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor","volume":"29","author":"Lucca","year":"1994","journal-title":"Neuropsychobiology"},{"issue":"2\u20133","key":"10.1016\/j.mehy.2015.10.001_b0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-0327(00)00209-3","article-title":"The effects of tryptophan depletion on mood and psychiatric symptoms","volume":"64","author":"Van der Does","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.mehy.2015.10.001_b0420","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","article-title":"Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","volume":"56","author":"Dahl","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0425","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/acps.12182","article-title":"Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome","volume":"129","author":"Anderson","year":"2014","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"10.1016\/j.mehy.2015.10.001_b0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000052085","article-title":"Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics","volume":"45","author":"van der Werf","year":"2001","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.mehy.2015.10.001_b0435","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0003-9993(99)90116-8","article-title":"Fatigue after stroke","volume":"80","author":"Ingles","year":"1999","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0440","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10549-004-2175-1","article-title":"Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy","volume":"89","author":"Roscoe","year":"2005","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"10.1016\/j.mehy.2015.10.001_b0445","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","article-title":"Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"21","author":"Morrow","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0450","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000348852","article-title":"Is poststroke depression a major depression?","volume":"35","author":"da Rocha e Silva","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"10.1016\/j.mehy.2015.10.001_b0455","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-3787(07)90406-3","article-title":"Fatigue in neurological disease: different patterns in stroke and multiple sclerosis","volume":"163","author":"Gramigna","year":"2007","journal-title":"Rev Neurol (Paris)"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0460","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/j.2048-7940.2006.tb00137.x","article-title":"Fatigue after stroke: relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy","volume":"31","author":"Michael","year":"2006","journal-title":"Rehabil Nurs"},{"key":"10.1016\/j.mehy.2015.10.001_b0465","series-title":"The struggle for recognition","author":"Honneth","year":"1995"},{"issue":"4","key":"10.1016\/j.mehy.2015.10.001_b0470","doi-asserted-by":"crossref","first-page":"e0123274","DOI":"10.1371\/journal.pone.0123274","article-title":"Medically unexplained and explained physical symptoms in the general population: association with prevalent and incident mental disorders","volume":"10","author":"van Eck van der Sluijs","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mehy.2015.10.001_b0475","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.socscimed.2005.07.030","article-title":"\u2018I just want permission to be ill\u2019: towards a sociology of medically unexplained symptoms","volume":"62","author":"Nettleton","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.mehy.2015.10.001_b0480","series-title":"Modernity and ambivalence","author":"Bauman","year":"1991"},{"key":"10.1016\/j.mehy.2015.10.001_b0485","series-title":"The problem of medical knowledge: examining the social construction of medicine","article-title":"Medicine: symbol and ideology","author":"Comaroff","year":"1982"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:19:18Z","timestamp":1759691958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715003722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0306987715003722"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.10.001","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A biopsychosocial model of fatigue and depression following stroke","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}